| Autor: |
Adatia, Adil, Magerl, Markus |
| Předmět: |
|
| Zdroj: |
Frontiers in Immunology; 2024, p1-4, 4p |
| Abstrakt: |
The article "Berotralstat for hereditary angioedema with C1 inhibitor deficiency: a practical guide for clinicians" discusses the use of berotralstat as a treatment option for hereditary angioedema due to C1 inhibitor deficiency. Berotralstat is an oral medication that inhibits plasma kallikrein and has been shown to reduce swelling attacks in patients. The article provides information on the drug's pharmacology, clinical efficacy, side effects, drug interactions, and guidance on transitioning patients to berotralstat from other long-term prophylaxis treatments. It emphasizes the importance of individualized care and monitoring for optimal patient outcomes. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
